Abstract
Mutations in the voltage-gated sodium channel subunit gene, SCN1A, are identified predominantly in patients with severe myoclonic epilepsy of infancy (SMEI) and in families with generalized epilepsy with febrile seizures plus (GEFS+). Patients with SMEI have predominantly truncating mutations or missense mutations in functionally important segments of the ion channel. In GEFS+ families predominantly missense mutations are found. The finding of a pathogenic SCN1A mutation may have consequences for the anti-epileptic treatment, helps to avoid further diagnostic procedures and provides information on the recurrence risk for siblings and other relatives.
Translated title of the contribution | Epilepsy and the SCN1A gene |
---|---|
Original language | Dutch |
Pages (from-to) | 254-258 |
Number of pages | 5 |
Journal | Tijdschrift voor Kindergeneeskunde |
Volume | 76 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 Jan 2008 |